CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3

Neuroimage Clin. 2016 Nov 10:13:97-105. doi: 10.1016/j.nicl.2016.11.007. eCollection 2017.

Abstract

This cross-sectional study investigated the correlation between the CAG repeat length and the degeneration of cerebellum in spinocerebellar ataxia type 3 (SCA3) patients based on neuroimaging approaches. Forty SCA3 patients were recruited and classified into two subgroups according to their CAG repeat lengths (≥ 74 and < 74). We measured each patient's Scale for the Assessment and Rating of Ataxia (SARA) score, N-acetylaspartate (NAA)/creatine (Cr) ratios based on magnetic resonance spectroscopy (MRS), and 3-dimensional fractal dimension (3D-FD) values derived from magnetic resonance imaging (MRI) results. Furthermore, the 3D-FD values were used to construct structural covariance networks based on graph theoretical analysis. The results revealed that SCA3 patients with a longer CAG repeat length demonstrated earlier disease onset. However, the CAG repeat length did not significantly correlate with their SARA scores, cerebellar NAA/Cr ratios or cerebellar 3D-FD values. Network dissociation between cerebellar regions and parietal-occipital regions was found in SCA3 patients with CAG ≥ 74, but not in those with CAG < 74. In conclusion, the CAG repeat length is uncorrelated with the change of SARA score, cerebellar function and cerebellar structure in SCA3. Nevertheless, a longer CAG repeat length may indicate early structural covariance network dissociation.

Keywords: Brain connectivity; Fractal dimension; Magnetic resonance imaging; Magnetic resonance spectroscopy; NAA; SCA3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aspartic Acid / analogs & derivatives*
  • Aspartic Acid / metabolism
  • Cerebellum* / diagnostic imaging
  • Cerebellum* / metabolism
  • Cerebellum* / pathology
  • Creatine / metabolism*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Machado-Joseph Disease* / diagnostic imaging
  • Machado-Joseph Disease* / metabolism
  • Machado-Joseph Disease* / pathology
  • Machado-Joseph Disease* / physiopathology
  • Magnetic Resonance Imaging / methods*
  • Magnetic Resonance Spectroscopy / methods
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Trinucleotide Repeats* / genetics

Substances

  • Aspartic Acid
  • N-acetylaspartate
  • Creatine